Top compounds associated with response to GADL1


Feature Type Standardized
Nominal ANOVA
mRNA Cisplatin GDSC1000 pan-cancer AAC 0.1 0.004
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.004
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.004
mRNA XMD13-2 GDSC1000 pan-cancer AAC 0.091 0.004
mRNA shikonin GDSC1000 pan-cancer AAC 0.1 0.004
mRNA UNC0638 CTRPv2 pan-cancer AAC 0.11 0.004
mRNA Vorinostat CTRPv2 pan-cancer AAC 0.097 0.004
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.095 0.005
mRNA tipifarnib CTRPv2 pan-cancer AAC 0.091 0.005
mRNA BRD-K13185470 CTRPv2 pan-cancer AAC -0.26 0.005
Download CSV